When a client with schizophrenia experiences hallucinations, the most effective approach is to maintain supportive therapy while connecting the client with medical treatment. Hallucinations are a symptom best addressed with appropriate psychiatric medication, and psychosocial support helps the client cope with distress, stay engaged in care, and function more effectively. The social worker should validate the experience, remain nonjudgmental, and avoid arguing about the reality of the hallucination, while actively coordinating with a psychiatrist to evaluate and manage possible medication. This combination—ongoing ego support plus referral for medical management—helps reduce symptoms, supports safety, and maintains the therapeutic alliance. Stopping therapy, dismissing symptoms, or focusing solely on self-reflection would neglect the biological basis of the illness and undermine treatment.

Korsakoff syndrome is marked by severe problems with forming and retrieving memories, often accompanied by confabulations—fabricated but seemingly plausible memories used to fill gaps. This pattern arises from thiamine (B1) deficiency related to chronic alcohol use, which damages memory-related brain regions such as the mammillary bodies and thalamus. Because of this, the memory profile seen in Korsakoff is best described as memory impairment with confabulation in the context of chronic alcoholism. It isn’t limited to a single sensory modality like auditory memory, nor is it simply isolated long-term memory loss or no memory issues at all; the hallmark is widespread memory disruption coupled with confabulation.

In DSM-5-TR, Generalized Anxiety Disorder is diagnosed when someone experiences excessive worry more days than not for at least six months about a variety of events or activities, and they find it hard to control that worry. This worry must be accompanied by at least three of six specific symptoms: restlessness or feeling keyed up, being easily fatigued, difficulty concentrating, irritability, muscle tension, and sleep disturbance. The symptoms must cause clinically significant distress or impairment in social, occupational, or other important areas of functioning, and the anxiety or symptoms can’t be better explained by another medical condition, substance, or another disorder. The best answer includes all of these elements: the six-month duration, worry about multiple domains, difficulty controlling the worry, at least three of the six symptoms, and impairment present. The other options miss one or more components—such as focusing on a single domain, lacking the required symptom count, or omitting the impairment/distress criterion—so they don’t fully match DSM-5-TR criteria for GAD.

Consent and confidentiality are at the heart of collateral interviews. When you reach out to someone other than the client to gather information, you must obtain the client’s informed consent to contact that person and to what information will be sought and shared. You also need to safeguard what is learned, sharing it only with people who are authorized and who need to know for the client’s care, and only as allowed by law and ethical guidelines. This respects the client’s autonomy, protects privacy, and supports trust and effective treatment planning. Collateral interviews should not be done without the client’s awareness, are not limited to emergency situations, and do not replace direct interviewing with the client.